The significance of secukinumab in the treatment of plaque psoriasis
Psoriasis is a chronic inflammatory skin disease that affects approximately 1–3% of the general population in Poland. It is estimated that in 70–80% of patients skin lesions are mild and require only topical medications. In severe plaque psoriasis, classic treatments often lead to a loss of efficacy...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2022-02-01
|
Series: | Przegląd Dermatologiczny |
Subjects: | |
Online Access: | https://www.termedia.pl/The-significance-of-secukinumab-in-the-treatment-of-plaque-psoriasis,56,46319,1,1.html |